Crop Life Science Balance Sheet Health
Financial Health criteria checks 2/6
Crop Life Science has a total shareholder equity of ₹787.1M and total debt of ₹402.8M, which brings its debt-to-equity ratio to 51.2%. Its total assets and total liabilities are ₹2.3B and ₹1.6B respectively. Crop Life Science's EBIT is ₹98.5M making its interest coverage ratio 2.3. It has cash and short-term investments of ₹13.1M.
Key information
51.2%
Debt to equity ratio
₹402.84m
Debt
| Interest coverage ratio | 2.3x |
| Cash | ₹13.13m |
| Equity | ₹787.05m |
| Total liabilities | ₹1.56b |
| Total assets | ₹2.35b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CLSL's short term assets (₹2.0B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: CLSL's short term assets (₹2.0B) exceed its long term liabilities (₹88.0M).
Debt to Equity History and Analysis
Debt Level: CLSL's net debt to equity ratio (49.5%) is considered high.
Reducing Debt: Insufficient data to determine if CLSL's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CLSL's debt is not well covered by operating cash flow (7.4%).
Interest Coverage: CLSL's interest payments on its debt are not well covered by EBIT (2.3x coverage).